Limakatso Lebina to Anti-HIV Agents
This is a "connection" page, showing publications Limakatso Lebina has written about Anti-HIV Agents.
Connection Strength
0,607
-
Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis. Front Immunol. 2024; 15:1415475.
Score: 0,126
-
Thetha Nami ngithethe nawe (Let's Talk): a stepped-wedge cluster randomised trial of social mobilisation by peer navigators into community-based sexual health and HIV care, including pre-exposure prophylaxis (PrEP), to reduce sexually transmissible HIV amongst young people in rural KwaZulu-Natal, South Africa. BMC Public Health. 2023 08 15; 23(1):1553.
Score: 0,116
-
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin. AIDS. 2023 09 01; 37(11):1651-1659.
Score: 0,114
-
Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa. Front Immunol. 2022; 13:965214.
Score: 0,108
-
Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial. Trials. 2020 Oct 30; 21(1):900.
Score: 0,095
-
Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV. BMC Infect Dis. 2021 May 22; 21(1):466.
Score: 0,025
-
Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV. AIDS. 2020 01 01; 34(1):63-71.
Score: 0,023